Targeting macrophages with baculovirus‐produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis-Reference-Cited by-同舟云学术

Targeting macrophages with baculovirus‐produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis

Published:2004-04-14 Issue:9 Volume:18 Page:971-973
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Bonten Erik J.¹,Wang Dongning¹,Toy James N.¹,Mann Linda¹,Mignardot Aurélie¹,Yogalingam Gouri¹,d'Azzo Alessandra¹

Affiliation:

1. Department of Genetics and Tumor Cell Biology St. Jude Children's Research Hospital MemphisTennessee38105

Funder

National Institutes of Health

Assisi Foundation of Memphis

American Lebanese Syrian Associated Charities

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.03-0941fje

Reference45 articles.

1. LYSOSOMAL STORAGE DISEASES

2. Inborn Errors of Mucopolysaccharide Metabolism

3. Receptor-mediated uptake of lysosomal enzymes;Sly W. S.;Prog. Clin. Biol. Res.,1978

4. Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances on the application of nanobiomimetic structures as drug delivery systems;Journal of Drug Delivery Science and Technology;2024-10

2. Gene therapy corrects the neurological deficits of mice with sialidosis;Gene Therapy;2024-02-07

3. Lysosomal sialidase NEU1, its intracellular properties, deficiency, and use as a therapeutic agent;Glycoconjugate Journal;2023-12

4. Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function;Advanced Drug Delivery Reviews;2023-06

5. Structure of the immunoregulatory sialidase NEU1;Science Advances;2023-05-19